First Time Loading...
J

Jeisys Medical Inc
KOSDAQ:287410

Watchlist Manager
Jeisys Medical Inc
KOSDAQ:287410
Watchlist
Price: 10 260 KRW -0.97% Market Closed
Updated: May 15, 2024

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Jeisys Medical Inc

Revenue
135.2B KRW
Cost of Revenue
-42.2B KRW
Gross Profit
93B KRW
Operating Expenses
-56.7B KRW
Operating Income
36.3B KRW
Other Expenses
-9.5B KRW
Net Income
26.8B KRW

Margins Comparison
Jeisys Medical Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
KR
Jeisys Medical Inc
KOSDAQ:287410
779.9B KRW
69%
27%
20%
US
Abbott Laboratories
NYSE:ABT
181.9B USD
55%
16%
14%
US
Intuitive Surgical Inc
NASDAQ:ISRG
141.2B USD
66%
25%
27%
US
Stryker Corp
NYSE:SYK
126.1B USD
64%
21%
16%
IE
Medtronic PLC
NYSE:MDT
111.8B USD
66%
20%
13%
US
Boston Scientific Corp
NYSE:BSX
109.1B USD
69%
17%
12%
US
Becton Dickinson and Co
NYSE:BDX
68.5B USD
41%
11%
6%
DE
Siemens Healthineers AG
XETRA:SHL
59.4B EUR
36%
10%
7%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
376.2B CNY
65%
35%
34%
US
Edwards Lifesciences Corp
NYSE:EW
54B USD
77%
29%
23%
US
Dexcom Inc
NASDAQ:DXCM
51.3B USD
63%
17%
17%
Country KR
Market Cap 779.9B KRW
Gross Margin
69%
Operating Margin
27%
Net Margin
20%
Country US
Market Cap 181.9B USD
Gross Margin
55%
Operating Margin
16%
Net Margin
14%
Country US
Market Cap 141.2B USD
Gross Margin
66%
Operating Margin
25%
Net Margin
27%
Country US
Market Cap 126.1B USD
Gross Margin
64%
Operating Margin
21%
Net Margin
16%
Country IE
Market Cap 111.8B USD
Gross Margin
66%
Operating Margin
20%
Net Margin
13%
Country US
Market Cap 109.1B USD
Gross Margin
69%
Operating Margin
17%
Net Margin
12%
Country US
Market Cap 68.5B USD
Gross Margin
41%
Operating Margin
11%
Net Margin
6%
Country DE
Market Cap 59.4B EUR
Gross Margin
36%
Operating Margin
10%
Net Margin
7%
Country CN
Market Cap 376.2B CNY
Gross Margin
65%
Operating Margin
35%
Net Margin
34%
Country US
Market Cap 54B USD
Gross Margin
77%
Operating Margin
29%
Net Margin
23%
Country US
Market Cap 51.3B USD
Gross Margin
63%
Operating Margin
17%
Net Margin
17%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Jeisys Medical Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
KR
Jeisys Medical Inc
KOSDAQ:287410
779.9B KRW
35%
23%
41%
42%
US
Abbott Laboratories
NYSE:ABT
181.9B USD
15%
8%
11%
9%
US
Intuitive Surgical Inc
NASDAQ:ISRG
141.2B USD
16%
14%
14%
19%
US
Stryker Corp
NYSE:SYK
126.1B USD
19%
9%
14%
11%
IE
Medtronic PLC
NYSE:MDT
111.8B USD
8%
5%
8%
6%
US
Boston Scientific Corp
NYSE:BSX
109.1B USD
9%
5%
8%
6%
US
Becton Dickinson and Co
NYSE:BDX
68.5B USD
5%
2%
5%
4%
DE
Siemens Healthineers AG
XETRA:SHL
59.4B EUR
8%
3%
7%
4%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
376.2B CNY
36%
25%
34%
46%
US
Edwards Lifesciences Corp
NYSE:EW
54B USD
22%
15%
22%
22%
US
Dexcom Inc
NASDAQ:DXCM
51.3B USD
29%
11%
15%
18%
Country KR
Market Cap 779.9B KRW
ROE
35%
ROA
23%
ROCE
41%
ROIC
42%
Country US
Market Cap 181.9B USD
ROE
15%
ROA
8%
ROCE
11%
ROIC
9%
Country US
Market Cap 141.2B USD
ROE
16%
ROA
14%
ROCE
14%
ROIC
19%
Country US
Market Cap 126.1B USD
ROE
19%
ROA
9%
ROCE
14%
ROIC
11%
Country IE
Market Cap 111.8B USD
ROE
8%
ROA
5%
ROCE
8%
ROIC
6%
Country US
Market Cap 109.1B USD
ROE
9%
ROA
5%
ROCE
8%
ROIC
6%
Country US
Market Cap 68.5B USD
ROE
5%
ROA
2%
ROCE
5%
ROIC
4%
Country DE
Market Cap 59.4B EUR
ROE
8%
ROA
3%
ROCE
7%
ROIC
4%
Country CN
Market Cap 376.2B CNY
ROE
36%
ROA
25%
ROCE
34%
ROIC
46%
Country US
Market Cap 54B USD
ROE
22%
ROA
15%
ROCE
22%
ROIC
22%
Country US
Market Cap 51.3B USD
ROE
29%
ROA
11%
ROCE
15%
ROIC
18%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More